CD19 and Bruton-type agammaglobulinemia: Instead of a complete block in B-cell maturation, we observed a lower frequency of the CD19+/CD34− B-cell population in the bone marrow of mice transplanted with HSPCs from patients with XLA if compared with WT HSPCs transplanted mice with gene editing reverting this phenotype.